AI Hangover Weighs On Chipmaker Shares Even With Solid Results
Signs of recovery in smartphone and computer demand have yet to provide the next tailwind for chip stocks
2023-11-02 09:59
Chipmaker SK Hynix Set to Grab Korea’s No. 2 Spot From LG Energy
South Korean chipmaker SK Hynix Inc. is poised to overtake LG Energy Solution Ltd. as the country’s second-largest
2023-11-02 09:51
Macklem Says Neutral Rate Likely Drifting Higher in Canada
Bank of Canada Governor Tiff Macklem said the neutral rate of interest is likely rising, and he wasn’t
2023-11-02 08:56
DoorDash projects core profit above estimates on steady demand
By Granth Vanaik DoorDash forecast fourth-quarter core profit above estimates after topping quarterly revenue expectations on Wednesday, boosted
2023-11-02 04:16
Exclusive-Cedar Fair explores merger with Six Flags-sources
By Greg Roumeliotis and David French NEW YORK U.S. amusement park operator Cedar Fair LP is exploring a
2023-11-02 02:16
Canadian factory sector downturn extends to longest since 2016
By Fergal Smith TORONTO Canada's manufacturing sector remained in contraction for a sixth straight month in October as
2023-11-01 21:57
Analysis-Canada's Trudeau should 'trim the sails' on spending, economists say
By Fergal Smith, Steve Scherer OTTAWA (Reuters) -As Canada grapples with a possible recession and its highest debt costs in
2023-11-01 21:22
Explainer-What's at stake as Alberta seeks to split from Canada Pension Plan
By Maiya Keidan TORONTO Canadian Finance Minister Chrystia Freeland will seek to challenge Alberta Premier Danielle Smith's plan
2023-11-01 18:15
Yen Rises on FX Warning; Asia Stocks to Open Mixed: Markets Wrap
The yen strengthened from near the weakest levels of the year after Japan’s foreign exchange chief said he
2023-11-01 08:23
AMD’s AI Optimism Helps Investors Look Past Tepid Forecast
Advanced Micro Devices Inc. said a new AI chip will generate $2 billion in sales next year, fueling
2023-11-01 07:59
U.S. FDA approves Amgen's biosimilar version of J&J's psoriasis drug
The U.S. Food and Drug Administration on Tuesday approved Amgen's biosimilar version of Johnson & Johnson's blockbuster psoriasis
2023-11-01 07:29
Canada Hedge Fund's Trades Halted After Losses, Manager's Death
The sudden death of a Toronto-based hedge fund manager has prompted an investigation into tens of millions of
2023-11-01 06:58